Fig. 6

Co-expression of sCLU and β-catenin was correlated with prognosis of HCC patients. a Representative immunohistochemical images of sCLU and β-catenin expression in normal tissues and HCC tissues at early or advanced stages. b Staining scores of sCLU in HCC tissues with different TNM stages. c Staining scores of β-catenin in HCC tissues with different TNM stages. d The 5-year overall survival according to sCLU expression (P = 0.047). e The survival curves according to β-catenin expression (P = 0.054). f The 5-year overall survival with co-expression of sCLU and β-catenin or other cases (P = 0.005). g The survival curves of different subgroup based on the expression levels of sCLU and β-catenin (P = 0.032). *P < 0.05; **P < 0.01. TNM, tumor-node-metastasis